GENOA, Italy, September 13, 2023 IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain disorders, today announced that Andrea P. Malizia, Ph.D., Chief Executive Officer, will present and participate in the "Advances in Approaches to Neurological Disorder" panel at the Sachs Associates 23rd Annual Biotech in Europe Forum, taking place September 20-21, 2023, in Basel, Switzerland.
Patient population benefitting most from enibarcimab treatment in septic shock can clearly be defined by two biomarkers, as shown by data presented todayIn the AdrenOSS-2 trial, the respective patient subgroup had a
ORYZON to Give Updates on Corporate Progress in September tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST Relief Therapeutics to Participate